[1
]
From TIMI Study Group, Brigham and Women's Hospital Heart and Vascular Center, Harvard
Medical School, Boston, MA (M.A.C., J.K., K.I., D.L.B.); French Alliance for Cardiovascular
Clinical Trials, Département Hospitalo-Universitaire, Fibrosis, Inflammation, Remodeling,
Université Paris-Diderot, Sorbonne Paris-Cité, Laboratory of Vascular Translational
Science, INSERM U-1148, Hôpital Bichat, Hopitaux Universitaires Paris-Nord Val de
Seine, Assistance Publique-Hôpitaux de Paris, Paris, France (P.G.S.); National Heart
Lung Institute, Imperial College, Royal Brompton Hospital, London, UK (P.G.S.); University
of North Carolina, Chapel Hill (S.C.S.); University of Michigan, Ann Arbor (K.E.);
Duke Clinical Research Institute, Durham, NC (E.M.O.); Tokai University, Kanagawa,
Japan (S.G.); and Emory University and the Atlanta VA Medical Center, Atlanta, GA
(P.W.F.W.).
[2
]
From TIMI Study Group, Brigham and Women's Hospital Heart and Vascular Center, Harvard
Medical School, Boston, MA (M.A.C., J.K., K.I., D.L.B.); French Alliance for Cardiovascular
Clinical Trials, Département Hospitalo-Universitaire, Fibrosis, Inflammation, Remodeling,
Université Paris-Diderot, Sorbonne Paris-Cité, Laboratory of Vascular Translational
Science, INSERM U-1148, Hôpital Bichat, Hopitaux Universitaires Paris-Nord Val de
Seine, Assistance Publique-Hôpitaux de Paris, Paris, France (P.G.S.); National Heart
Lung Institute, Imperial College, Royal Brompton Hospital, London, UK (P.G.S.); University
of North Carolina, Chapel Hill (S.C.S.); University of Michigan, Ann Arbor (K.E.);
Duke Clinical Research Institute, Durham, NC (E.M.O.); Tokai University, Kanagawa,
Japan (S.G.); and Emory University and the Atlanta VA Medical Center, Atlanta, GA
(P.W.F.W.). DLBHATTMD@post.harvard.edu.